Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1035 (116th)

Prescription Drug Price Transparency Act

referredUnited States· United States Congress· EN

Introduced

7 February 2019

Last action

7 February 2019 · Introduced

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Collins, Doug [R-GA-9], Rep. Loebsack, David [D-IA-2], Rep. Roe, David P. [R-TN-1], Rep. Westerman, Bruce [R-AR-4], Rep. Rice, Kathleen M. [D-NY-4], Rep. King, Steve [R-IA-4], Rep. Clarke, Yvette D. [D-NY-9], Rep. Scott, Austin [R-GA-8], Rep. Hice, Jody B. [R-GA-10], Rep. Vela, Filemon [D-TX-34], Rep. Raskin, Jamie [D-MD-8], Rep. McMorris Rodgers, Cathy [R-WA-5], Sen. Welch, Peter [D-VT], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Crawford, Eric A. "Rick" [R-AR-1], Rep. Peterson, Collin C. [D-MN-7], Rep. Byrne, Bradley [R-AL-1], Rep. Newhouse, Dan [R-WA-4], Rep. Herrera Beutler, Jaime [R-WA-3], Rep. Gonzalez, Vicente [D-TX-34], Sen. Marshall, Roger [R-KS], Rep. Palazzo, Steven M. [R-MS-4], Sen. Budd, Ted [R-NC], Rep. Roby, Martha [R-AL-2], Rep. Doggett, Lloyd [D-TX-37], Rep. Brooks, Mo [R-AL-5], Rep. Hill, J. French [R-AR-2], Rep. Davids, Sharice [D-KS-3], Rep. Visclosky, Peter J. [D-IN-1], Rep. Loudermilk, Barry [R-GA-11], Rep. Meuser, Daniel [R-PA-9], Rep. Gabbard, Tulsi [D-HI-2], Rep. Rogers, Mike D. [R-AL-3], Rep. Sarbanes, John P. [D-MD-3], Rep. Cline, Ben [R-VA-6], Rep. Posey, Bill [R-FL-8], Rep. Lesko, Debbie [R-AZ-8], Rep. Keller, Fred [R-PA-12], Rep. Thompson, Glenn [R-PA-15]

Subjects

Healthcare

Source updated

4 February 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Prescription Drug Price Transparency Act This bill establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs). Specifically, such PDPs and carriers must disclose specified information to pharmacies regarding applicable standards for reimbursement that are based on drug costs, including the sources used to update such standards. Additionally, such PDPs and carriers may not contract with PBMs that require, or that provide an incentive for, plan enrollees to use pharmacies that have a shared ownership interest with the PBM.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 7 February 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 7 February 2019

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 7 February 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 7 February 2019

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 7 February 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 7 February 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 7 February 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.